Evidence map›Paper›PMID 39007641›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

ATM-dependent Phosphorylation of Nemo SQ Motifs Is Dispensable for Nemo-mediated Gene Expression Changes in Response to DNA Double-Strand Breaks.

Rebecca A Glynn, Katharina E Hayer, Craig H Bassing

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rebecca A GlynnCell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-3916-6900
Katharina E HayerDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Craig H BassingCell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-1703-0786

Funding

TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
Topological Control of Antigen Receptor Loci during Lymphocyte DevelopmentR01AI130231 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H, OLTZ, EUGENE M · 2017 to 2021
$3.8M
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J RecombinationR01AI172163 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2022 to 2025
$2.2M
Elucidating Lymphocyte Allelic Exclusion Mechanisms and FunctionsR01AI143661 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2019 to 2023
$2.2M
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J RecombinationR01AI112621 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2015 to 2019
$1.9M
Defining the Mechanism and Function of DNA Double Strand Break Induced Inhibition of V(D)J RecombinationF31AI152354 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GLYNN, REBECCA ANN · 2021 to 2023
$109k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F31 AI 152354HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI 112621HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI 130231HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI 172163HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32 GM-07229NIAID NIH HHS F31 AI152354NIAID NIH HHS R01 AI112621NIAID NIH HHS R01 AI130231NIAID NIH HHS R01 AI143661NIAID NIH HHS R01 AI172163NIGMS NIH HHS T32 GM007229
6 · The paper itself

Abstract

In response to DNA double-strand breaks (DSBs), the ATM kinase activates NF-κB factors to stimulate gene expression changes that promote survival and allow time for cells to repair damage. In cell lines, ATM can activate NF-κB transcription factors via two independent, convergent mechanisms. One is ATM-mediated phosphorylation of nuclear NF-κB essential modulator (Nemo) protein, which leads to monoubiquitylation and export of Nemo to the cytoplasm where it engages the IκB kinase (IKK) complex to activate NF-κB. Another is DSB-triggered migration of ATM into the cytoplasm, where it promotes monoubiquitylation of Nemo and the resulting IKK-mediated activation of NF-κB. ATM has many other functions in the DSB response beyond activation of NF-κB, and Nemo activates NF-κB downstream of diverse stimuli, including developmental or proinflammatory stimuli such as LPSs. To elucidate the in vivo role of DSB-induced, ATM-dependent changes in expression of NF-κB-responsive genes, we generated mice expressing phosphomutant Nemo protein lacking consensus SQ sites for phosphorylation by ATM or related kinases. We demonstrate that these mice are viable/healthy and fertile and exhibit overall normal B and T lymphocyte development. Moreover, treatment of their B lineage cells with LPS induces normal NF-κB-regulated gene expression changes. Furthermore, in marked contrast to results from a pre-B cell line, primary B lineage cells expressing phosphomutant Nemo treated with the genotoxic drug etoposide induce normal ATM- and Nemo-dependent changes in expression of NF-κB-regulated genes. Our data demonstrate that ATM-dependent phosphorylation of Nemo SQ motifs in vivo is dispensable for DSB-signaled changes in expression of NF-κB-regulated genes.

Indexed as

Ataxia Telangiectasia Mutated ProteinsDNA Breaks, Double-StrandedNF-kappa BAmino Acid MotifsAnimalsEtoposideGene Expression RegulationI-kappa B KinaseIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutPhosphorylationAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseEtoposideI-kappa B KinaseIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa B

Identifiers

PMID39007641
PMCPMC11348802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.